Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| CONMED Corporation | CNMD | NYSE | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 74.45 | 03:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 74.45 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 61.05 - 138.47 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 74.45 | USD |
CONMED Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.12B | 30.78M | - | 1.24B | 64.46M | 2.09 | 48.43 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CONMED News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNMD Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 77.18 | 78.58 | 73.02 | 76.46 | 339,560 | -2.73 | -3.54% |
| 1 Month | 73.51 | 78.58 | 71.35 | 75.24 | 421,556 | 0.94 | 1.28% |
| 3 Months | 76.21 | 81.22 | 61.05 | 72.85 | 521,416 | -1.76 | -2.31% |
| 6 Months | 109.26 | 117.27 | 61.05 | 83.54 | 532,159 | -34.81 | -31.86% |
| 1 Year | 132.22 | 138.47 | 61.05 | 94.88 | 447,302 | -57.77 | -43.69% |
| 3 Years | 136.43 | 159.11 | 61.05 | 104.46 | 371,433 | -61.98 | -45.43% |
| 5 Years | 100.14 | 159.11 | 37.66 | 100.65 | 358,751 | -25.69 | -25.65% |
CONMED Description
| Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%. |
